PHILADELPHIA, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Passage Bio, a genetic medicines company developing AAV-delivered gene therapies for the treatment of rare monogenic central nervous system (CNS) ...

-- Collaboration to explore role of HDAC6 in multiple forms of CMT disease ---- Company appoints Dr. David Herrmann to Scientific Advisory Board -- WALTHAM, Mass.--(BUSINESS WIRE)--Regenacy ...

PHILADELPHIA -- A cocktail of three repurposed drugs targeting multiple disease pathways appeared effective in treating Charcot-Marie-Tooth type 1A, results of the phase III PLEO-CMT trial presented ...

This week we are going to switch from orthopedic conditions to a neurologic condition which is relatively rare but occurs as a result of a genetic mutation and is a hereditary peripheral neuropathy.

The hereditary motor and sensory neuropathies (HMSNs) are a clinically heterogeneous group of peripheral neuropathies, characterized by slowly progressive weakness and atrophy of the distal limb ...

Hereditary Neuropathy Foundation’s (HNF) mission is to increase awareness and accurate diagnosis of Charcot-Marie-Tooth (CMT) and related inherited neuropathies and support people living with CMT and ...

GeneDx’s Hereditary Neuropathy Panel will be available free of charge to individuals at risk for or suspected of having GAN Taysha will collaborate with Hereditary Neuropathy Foundation and ...

This review provides a concise overview of the epidemiology, etiology, history, diagnostic criteria, and management of Charcot-Marie-Tooth disease. Peripheral nervous system maintains its anatomic ...